A Phase 2 Clinical Trial for the Treatment of Moderate to Severe Inflammatory Rosacea with its Proprietary Minocycline Topical Gel
- Monday, Jan. 26 (14:00)
"Quality by Design Principles in the Development of Chemical Processes to Manufacture Small Molecule Drug Substances"
Marco Gil, Director of RD Chemistry at Hovione.
- Tuesday, Jan. 27 (8:30)
"PAT as an Advantage Developing Chemical Synthesis Processes for Drug Substances Manufacturing"
Cláudio Rebelo, Manufacturing Technical Expert at Hovione.